Focused in vivo delivery of plasmid DNA to the porcine vascular wall via intravascular ultrasound destruction of microbubbles

Journal of Vascular Research

Volumn 47, Issue 3, 2010, Pages 270-274

  Phillips, Linsey C ^a   Klibanov, Alexander L ^a,b   Bowles, Douglas K ^c   Ragosta, Michael ^b   Hossack, John A ^a   Wamhoff, Brian R ^a,b  

^a University of Virginia   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Artery; Gene transfer; Intravascular ultrasound; Microbubbles; Pig

Indexed keywords

PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; DNA TRANSFECTION; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE TRANSFER; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MICROBUBBLE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; SWINE; TRANSGENE; ULTRASOUND TRANSDUCER;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CELLS, CULTURED; CONTRAST MEDIA; CORONARY VESSELS; EQUIPMENT DESIGN; LUMINESCENT PROTEINS; MICROBUBBLES; MICROSCOPY, FLUORESCENCE; PLASMIDS; RATS; SWINE; TIME FACTORS; TRANSFECTION; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 70449623638     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000258905     Document Type: Article

References (10)

1. Aikawa M, Sakomura Y, Ueda M, Kimura K, Manabe I, Ishiwata S, Komiyama N, Yama-guchi H, Yazaki Y, Nagai R: Redifferentia-tion of smooth muscle cells after coronary angioplasty determined via myosin heavy chain expression. Circulation 1997; 96:82-90.
2. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM: Clopi-dogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007; 297: 159-168.
3. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C, BASKET-LATE Investigators: Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006; 48: 2584-2591.
4. Rahim AA, Taylor SL, Bush NL, ter Haar GR, Bamber JC, Porter CD: Spatial and acoustic pressure dependence of microbubble-medi-ated gene delivery targeted using focused ultrasound. J Gene Med 2006; 8:1347-1357.
5. Christiansen P, French BA, Klibanov AL, Kaul S, Lindner JR: Targeted tissue transfec-tion with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol 2003; 29:1759-1767.
6. Tharp DL, Wamhoff BR, Wulff H, Raman G, Cheong A, Bowles DK:.Local delivery of the K(Ca)3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis. Arterioscler Thromb Vasc Biol 2008; 28: 1084-1089.
7. Hashiya N, Aoki M, Tachibana K, Taniyama Y, Yamasaki K, Hiraoka K, Makino H, Yasu-fumi K, Ogihara T, Morishita R: Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model. Biochem Biophys Res Commun 2004; 317: 508-514.
8. Porter TR, Xie F, Knapp D, Iversen P, Marky LA, Tsutsui JM, Maiti S, Lof J, Radio SJ, Kip-shidze N: Targeted vascular delivery of anti-sense molecules using intravenous micro-bubbles. Cardiovasc Revasc Med 2006; 7: 25-33.
9. Ferrara K, Pollard R, Bordeni M: Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Ann Rev Biomed Eng 2007; 9: 415-447.
10. Mayer CR, Bekeredjian R: Ultrasonic gene and drug delivery to the cardiovascular system. Adv Drug Deliv Rev 2008; 60:1177-1192.